MedPath

Protein S human

Generic Name
Protein S human
Brand Names
Balfaxar, Beriplex, Kcentra, Octaplex
Drug Type
Biotech
Unique Ingredient Identifier
90J3F6N5FN

Overview

Protein S human is a vitamin K-dependent plasma glycoprotein which has antcoagulant properties . It serves as a negative feedback mechanism in the coagulation cascade.

Indication

For use in the emergency reversal of coagulation factor deficiency in patients recieving vitamin K antagonist therapy . Protein S is administered as part of a cocktail containing several other coagulation factors.

Associated Conditions

  • Vitamin K antagonist induced major bleeding

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor

No clinical trials found

No clinical trials found for this drug

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
OCTAPLEX POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 500 IU
SIN14933P
INJECTION, POWDER, FOR SOLUTION
240 - 640 IU/vial
1/28/2016

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
OCTAPLEX
octapharma pharmazeutika produktionsges m b h
02294664
Kit ,  Powder For Solution - Intravenous
640 UNIT / VIAL
7/8/2008
BERIPLEX P/N 1000
csl behring canada inc
02410826
Powder For Solution - Intravenous
1360 UNIT
11/21/2013
BERIPLEX P/N 500
csl behring canada inc
02359251
Powder For Solution - Intravenous
680 UNIT
7/28/2011
OCTAPLEX
octapharma pharmazeutika produktionsges m b h
02434970
Powder For Solution ,  Kit - Intravenous
1280 UNIT / VIAL
8/11/2015

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.